Systemic sclerosis (SSc) is a rare autoimmune disease with the highest case-fatality rate of all connective tissue diseases. Current efforts to determine patient response to a given treatment using the modified Rodnan skin score (mRSS) are complicated by interclinician variability, confounding, and the time required between sequential mRSS measurements to observe meaningful change. There is an unmet critical need for an objective metric of SSc disease severity. Here, we performed an integrated, multicohort analysis of SSc transcriptome data across 7 datasets from 6 centers composed of 515 samples. Using 158 skin samples from SSc patients and healthy controls recruited at 2 centers as a discovery cohort, we identified a 415-gene expression signature specific for SSc, and validated its ability to distinguish SSc patients from healthy controls in an additional 357 skin samples from 5 independent cohorts. Next, we defined the SSc skin severity score (4S). In every SSc cohort of skin biopsy samples analyzed in our study, 4S correlated significantly with mRSS, allowing objective quantification of SSc disease severity. Using transcriptome data from the largest longitudinal trial of SSc patients to date, we showed that 4S allowed us to objectively monitor individual SSc patients over time, as (a) the change in 4S of a patient is significantly correlated with change in the mRSS, and (b) the change in 4S at 12 months of treatment could predict the change in mRSS at 24 months. Our results suggest that 4S could be used to distinguish treatment responders from nonresponders prior to mRSS change. Our results demonstrate the potential clinical utility of a novel robust molecular signature and a computational approach to SSc disease severity quantification.
Shane Lofgren, Monique Hinchcliff, Mary Carns, Tammara Wood, Kathleen Aren, Esperanza Arroyo, Peggie Cheung, Alex Kuo, Antonia Valenzuela, Anna Haemel, Paul J. Wolters, Jessica Gordon, Robert Spiera, Shervin Assassi, Francesco Boin, Lorinda Chung, David Fiorentino, Paul J. Utz, Michael L. Whitfield, Purvesh Khatri
Title and authors | Publication | Year |
---|---|---|
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis
Gunes I, Bernstein E, Cowper SE, Panse G, Pradhan N, Camacho LD, Page N, Bundschuh E, Williams A, Carns M, Aren K, Fantus S, Volkmann ER, Bukiri H, Correia C, Wang R, Kolachalama V, Wilson FP, Mawe S, Mahoney JM, Hinchcliff M |
Research Square | 2024 |
Polygenic scores for psychiatric disorders in a diverse postmortem brain tissue cohort
Duncan L, Shen H, Schulmann A, Li T, Kolachana B, Mandal A, Feng N, Auluck P, Marenco S |
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2023 |
Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients
Makinde HK, Dunn JL, Gadhvi G, Carns M, Aren K, Chung AH, Muhammad LN, Song J, Cuda CM, Dominguez S, Pandolfino JE, Dematte D\u2019Amico JE, Budinger GS, Assassi S, Frech TM, Khanna D, Shaeffer A, Perlman H, Hinchcliff M, Winter DR |
Arthritis & Rheumatism | 2023 |
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation.
Ayoglu B, Donato M, Furst DE, Crofford LJ, Goldmuntz E, Keyes-Elstein L, James J, Macwana S, Mayes MD, McSweeney P, Nash RA, Sullivan KM, Welch B, Pinckney A, Mao R, Chung L, Khatri P, Utz PJ |
Annals of the rheumatic diseases | 2023 |
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine
Benfaremo D, Agarbati S, Mozzicafreddo M, Paolini C, Svegliati S, Moroncini G |
International journal of molecular sciences | 2023 |
Loss of Protein Kinase D2 Activity Protects Against Bleomycin-Induced Dermal Fibrosis in Mice.
Chen L, Zhao J, Chao Y, Roy A, Guo W, Qian J, Xu W, Domsic RT, Lafyatis R, Lu B, Deng F, Wang QJ |
Laboratory Investigation | 2023 |
Dendritic cell-derived epiregulin maintains scleroderma skin and lung fibrosis
Ian Odell, Holly Steach, Stephen Gauld, Tracy Carr, Joseph Wetter, Lucy Phillips, Monique Hinchcliff, Richard Flavell |
Science Immunology | 2022 |
A robust gene expression signature for NASH in liver expression data
Y Hasin-Brumshtein, S Sakaram, P Khatri, Y He, T Sweeney |
Scientific Reports | 2022 |
A roadmap for translational cancer glycoimmunology at single cell resolution
A Peixoto, A Miranda, L Santos, J Ferreira |
Journal of Experimental & Clinical Cancer Research | 2022 |
Comprehensive multi-cohort transcriptional meta-analysis of muscle diseases identifies a signature of disease severity
Walsh CJ, Batt J, Herridge MS, Mathur S, Bader GD, Hu P, Khatri P, dos Santos CC |
Scientific Reports | 2022 |
Hub genes associated with immune cell infiltration in breast cancer, identified through bioinformatic analyses of multiple datasets
Zhao H, Dang R, Zhu Y, Qu B, Sayyed Y, Wen Y, Liu X, Lin J, Li L |
Cancer biology & medicine | 2022 |
Tenascin-C in fibrosis in multiple organs: translational implications
Bhattacharyya S, Midwood KS, Varga J |
Seminars in Cell & Developmental Biology | 2022 |
Cross-Tissue Transcriptomic Analysis Leveraging Machine Learning Approaches Identifies New Biomarkers for Rheumatoid Arthritis
D Rychkov, J Neely, T Oskotsky, S Yu, N Perlmutter, J Nititham, A Carvidi, M Krueger, A Gross, LA Criswell, JF Ashouri, M Sirota |
Frontiers in immunology | 2021 |
A Multi-mRNA Prognostic Signature for Anti-TNFα Therapy Response in Patients with Inflammatory Bowel Disease
S Sakaram, Y Hasin-Brumshtein, P Khatri, YD He, TE Sweeney |
Diagnostics | 2021 |
Current Concepts on the Pathogenesis of Systemic Sclerosis
ME Truchetet, NC Brembilla, C Chizzolini |
Clinical Reviews in Allergy & Immunology | 2021 |
Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
V Farutin, E Kurtagic, JR Pradines, I Capila, MD Mayes, M Wu, AM Manning, S Assassi |
Arthritis Research & Therapy | 2021 |
Large‐Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis
C Bellocchi, J Ying, EA Goldmuntz, L KeyesElstein, J Varga, ME Hinchcliff, MA Lyons, P McSweeney, DE Furst, R Nash, LJ Crofford, B Welch, JG Goldin, A Pinckney, MD Mayes, KM Sullivan, S Assassi |
Arthritis & Rheumatology | 2021 |
Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over time
B Skaug, M Lyons, W Swindell, G Salazar, M Wu, T Tran, J Charles, C Vershel, M Mayes, S Assassi |
Annals of the rheumatic diseases | 2021 |
Integrated, Multi-Cohort Analysis Reveals Unified Signature of Systemic Lupus Erythematosus
Winston A. Haynes, David James Haddon, Vivian Diep, Avani Khatri, Erika Bongen, Gloria Yiu, Imelda Balboni, Christopher R. Bolen, Rong Mao, Paul J. Utz, Purvesh Khatri |
JCI Insight | 2020 |
Genomics of Human Fibrotic Diseases: Disordered Wound Healing Response
RC Stone, V Chen, J Burgess, S Pannu, M Tomic-Canic |
International journal of molecular sciences | 2020 |
Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement
K Showalter, R Spiera, C Magro, P Agius, V Martyanov, JM Franks, R Sharma, H Geiger, TA Wood, Y Zhang, CR Hale, J Finik, ML Whitfield, DE Orange, JK Gordon |
Annals of the rheumatic diseases | 2020 |
A generalizable 29-mRNA neural-network classifier for acute bacterial and viral infections
MB Mayhew, L Buturovic, R Luethy, U Midic, AR Moore, JA Roque, BD Shaller, T Asuni, D Rawling, M Remmel, K Choi, J Wacker, P Khatri, AJ Rogers, TE Sweeney |
Nature Communications | 2020 |
High-throughput quantitative histology in systemic sclerosis skin disease using computer vision
C Correia, S Mawe, S Lofgren, RG Marangoni, J Lee, R Saber, K Aren, M Cheng, S Teaw, A Hoffmann, I Goldberg, SE Cowper, P Khatri, M Hinchcliff, JM Mahoney |
Arthritis Research & Therapy | 2020 |
Lenabasum for Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
M Hinchcliff |
Arthritis & Rheumatology | 2020 |
Data Heterogeneity: The Enzyme to Catalyze Translational Bioinformatics?
EM Cahan, P Khatri |
Journal of Medical Internet Research | 2020 |
A machine learning-based clinical tool for diagnosing myopathy using multi-cohort microarray expression profiles
A Tran, CJ Walsh, J Batt, CC dos Santos, P Hu |
Journal of Translational Medicine | 2020 |
Big data in systemic sclerosis: Great potential for the future
M Radic, T Frech |
Journal of Scleroderma and Related Disorders | 2020 |
Shared and distinct mechanisms of fibrosis
JH Distler, AH Györfi, M Ramanujam, ML Whitfield, M Königshoff, R Lafyatis |
Nature Reviews Rheumatology | 2019 |
Evolving Insights into the Cellular and Molecular Pathogenesis of Fibrosis in Systemic Sclerosis
B Korman |
Translational research : the journal of laboratory and clinical medicine | 2019 |
A 20-Gene Set Predictive of Progression to Severe Dengue
M Robinson, TE Sweeney, R Barouch-Bentov, MK Sahoo, L Kalesinskas, F Vallania, AM Sanz, E Ortiz-Lasso, LL Albornoz, F Rosso, JG Montoya, BA Pinsky, P Khatri, S Einav |
Cell Reports | 2019 |
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile
B Skaug, D Khanna, WR Swindell, ME Hinchcliff, TM Frech, VD Steen, FN Hant, JK Gordon, AA Shah, L Zhu, WJ Zheng, JL Browning, AM Barron, M Wu, S Visvanathan, P Baum, JM Franks, ML Whitfield, VK Shanmugam, RT Domsic, FV Castelino, EJ Bernstein, N Wareing, MA Lyons, J Ying, J Charles, MD Mayes, S Assassi |
Annals of the rheumatic diseases | 2019 |
Moving towards a molecular taxonomy of autoimmune rheumatic diseases
G Barturen, L Beretta, R Cervera, RV Vollenhoven, ME Alarcón-Riquelme |
Nature Reviews Rheumatology | 2018 |
Advanced model systems and tools for basic and translational human immunology
LE Wagar, RM DiFazio, MM Davis |
Genome Medicine | 2018 |
Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy
S Bhattacharyya, J Varga |
Immunology Letters | 2018 |
KLRD1-expressing natural killer cells predict influenza susceptibility
E Bongen, F Vallania, PJ Utz, P Khatri |
Genome Medicine | 2018 |
Thinking BIG rheumatology: how to make functional genomics data work for you
DR Winter |
Arthritis Research & Therapy | 2018 |
Single-cell epigenetics – Chromatin modification atlas unveiled by mass cytometry
P Cheung, F Vallania, M Dvorak, SE Chang, S Schaffert, M Donato, AM Rao, R Mao, PJ Utz, P Khatri, AJ Kuo |
Clinical Immunology | 2018 |
Gene annotation bias impedes biomedical research
WA Haynes, A Tomczak, P Khatri |
Scientific Reports | 2018 |
Leveraging heterogeneity across multiple datasets increases cell-mixture deconvolution accuracy and reduces biological and technical biases
F Vallania, A Tam, S Lofgren, S Schaffert, TD Azad, E Bongen, W Haynes, M Alsup, M Alonso, M Davis, E Engleman, P Khatri |
Nature Communications | 2018 |
The Mechanistic Implications of Gene Expression Studies in SSc: Insights From Systems Biology
JN Taroni, JM Mahoney, ML Whitfield |
Current Treatment Options in Rheumatology | 2017 |
Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist’s, Clinician’s, and Patient’s Perspective
M Cossu, L Beretta, P Mosterman, MJ de Hair, TR Radstake |
Clinical Reviews in Allergy & Immunology | 2017 |